Increasing life expectancy along with increased pollution has led to cancers and neurodegenerative disorders becoming more prominent worldwide. Biotech companies have turned to expensive, sophisticated, yet patentable, advanced technologies such as artificial intelligence and gene editing, just to come to the realization that their most promising therapeutic approach involves targeting the overactive immune system and reducing systemic inflammation. All things we can achieve naturally, without toxicity and side effects. More than ever, the Beljanski Foundation is investing in research programs that bring answers to our most pressing health needs, the natural way.

Just Published: New Research on Anti-Cancer Effects of Golden Ginkgo Leaf Extract

A newly published paper shows that the Golden Ginkgo Leaf Extract (GGLE) fights cancer progression by inhibiting two major survival strategies of cancer cells: blocking the recruitment of blood vessels that feed tumor growth, and curtailing the invasion of tissues that enables metastasis. This study, focusing on melanoma, was conducted at the University of Kansas Medical Center in Dr. Qi Chen’s laboratory, a longtime collaborator of the Beljanski Foundation. Cancers use more than one strategy to progress. In addition to dividing rapidly, tumor cells release a signal called angiogenin that stimulates new blood supply for them and strengthens their ability to spread by penetrating neighboring tissues. GGLE specifically inhibits the release of this pro-cancer signal, thereby suppressing tumor growth and metastasis. Combinations of GGLE for its anti-vascular and anti-metastatic activity with the Pao pereira and Rauwolfia vomitoria extracts for the direct killing of cancer cells provide a formidable, non-toxic, triple-action approach to the fight against cancer.

Click here to read the full publication

Ongoing: A Clinical Trial for Long COVID Patients

The Beljanski Foundation is sponsoring a new clinical trial for patients with Long COVID because of the urgent need for a new and successful treatment. Anecdotal reports from patients experiencing lingering symptoms from an infection with SARS-CoV-2 started to emerge shortly after the beginning of the pandemic, and the term “Long COVID” was coined to name this condition and alert the scientific community. Upwards of 65 million people worldwide are now suffering from this condition. The goal is to test whether administration of a special preparation of small RNA fragments, originally developed by Dr. Mirko Beljanski, will work by stimulating stem cells in bone marrow to produce new immune cells. Previous research conducted on this special preparation at Cancer Treatment Centers of America confirmed its safety and effectiveness for treating thrombocytopenia (low platelets) caused by chemotherapy. Thrombocytopenia has been seen in a significant number of Long COVID patients and low platelets are associated with fatigue-a major symptom of Long COVID. The trial will also reveal the potential of the RNA fragments to re-balance immunity in these patients. While the critical role of RNA primers was first discovered by Okazaki, those short segments of RNA acting as primers for initiating the synthesis of new strands of DNA were originally developed by Dr. Beljanski while working at the Pasteur Institute in Paris, France. The fragments work by stimulating stem cells in bone marrow to produce our immune cells. They have been available as a dietary ingredient in the US since the 90s and it is a commercial preparation made available by Maison Beljanski which will be used for the clinical trial. Enrollment for the clinical trial is already on its way in Europe. The findings are expected to provide valuable insight into whether improving bone marrow function and patient immunity is a pathway for successful Long COVID treatment.

“Platelet levels have been measured in depressed patients and have been found to be decreased when compared to normal controls. Therefore, interference in this process might be a promising avenue for further research to address mild thrombocytopenia in people with Long COVID, along with the most common side effects of this condition, which are fatigue and depression”

says Dr. John Hall, Director of Research at the Beljanski Foundation. The Foundation needs $80,000 to fund this research program. Your support will be fully tax-deductible to the extent allowed by the law.

Click here to donate to long covid research

Coming Soon: Breast Cancer Stem Cells Research

While several studies have concluded that the two botanicals Pao pereira and Rauwolfia vomitoria both represent potential therapeutic agents for the treatment of pancreatic and ovarian cancers by targeting cancer stem cells, the Beljanski Foundation has also seen exciting results on breast cancer with a study comparing different kinds of green teas: >>https://www.beljanski.org/wp-content/uploads/2023/05/ONKOTEA-EC-Nutrition-S-Beljanski-J-Hall-2021.pd It would be, therefore, extremely valuable to see if those results could be reproduced and extended to breast cancer stem cells. Cancer stem cells (CSCs) are a type of stem cell-specific to cancer that is able to reproduce through self-renewal and regeneration into new tumor cells. Cancer stem cells are most dangerous as they are resistant to chemotherapy and cause relapse by creating new tumors. It is critical to find treatments for cancer stem cells to prevent this disease from resurfacing in a person again and again. With this new program and for the first time ever, the three botanicals (Pao pereira, Rauwolfia vomitoria and green tea extract) will be mixed and studied together for their ability to inhibit breast cancer stem cells. Further research will also be needed to evaluate the safety and effectiveness of this approach in clinical trials and to understand its potential limitations and side effects. The Beljanski Foundation has a goal to raise $240,000 for funding its breast cancer stem cells research program. While this research can be challenging, it is crucial to advancing our understanding of breast cancer and developing new therapies for this disease.

Click here to donate to breast cancer stem cell research

2023 Events

Learn How to Prevent and Heal Cancer Using Natural, Holistic and Integrative Methods from World Leading Doctors and Cancer-Conquerors. Use the promo code BELJANSKI for 10% off your ticket!

Click here for your in-person or virtual tickets right now

Virtual Healthy Tuesdays

• Jul. 11: Food of the future, what will we eat tomorrow?
• Sep. 19: Group Health Coaching
• Nov. 9: Breast Cancer: Stem Cells and Metastasis
• Dec. 12: Angels & Champions for Cancer Research

Tradeshows

• Jul. 29-Aug 1: Advancing Integrative Practice Together in Chicago, IL
• Sep. 2-6: 48th Annual Cancer Control Society Convention 2023 in Glendale, CA
• Sep. 23-24: 16th International Natural Health & Food Expo in Sarasota, FL

Why is it important to support the Beljanski Foundation?

The Beljanski Foundation’s mission is to honor the legacy of Dr. Mirko Beljanski by advancing scientific research on natural compounds for the prevention and treatment of cancer and other chronic diseases. We are dedicated to conducting rigorous scientific research using the latest techniques and technologies to ensure that our findings are accurate and reliable. We are also committed to sharing our knowledge and expertise with the scientific community and the public to promote greater awareness and understanding of the potential benefits of natural compounds for human health.

Click here to donate to the Beljanski Foundation